228 related articles for article (PubMed ID: 26371437)
1. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
[TBL] [Abstract][Full Text] [Related]
2. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
3. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging.
Bae KH; Kim YB; Lee Y; Hwang J; Park H; Park TG
Bioconjug Chem; 2010 Mar; 21(3):505-12. PubMed ID: 20166678
[TBL] [Abstract][Full Text] [Related]
4. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
5. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
6. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy.
Zhou T; Zhang S; Zhang L; Jiang T; Wang H; Huang L; Wu H; Fan Z; Jing S
Acta Biomater; 2023 Jul; 164():496-510. PubMed ID: 37054962
[TBL] [Abstract][Full Text] [Related]
7. Activatable molecular MRI nanoprobe for tumor cell imaging based on gadolinium oxide and iron oxide nanoparticle.
Li J; Wang S; Wu C; Dai Y; Hou P; Han C; Xu K
Biosens Bioelectron; 2016 Dec; 86():1047-1053. PubMed ID: 27501342
[TBL] [Abstract][Full Text] [Related]
8. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
9. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
10. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
11. Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents.
Chen R; Ling D; Zhao L; Wang S; Liu Y; Bai R; Baik S; Zhao Y; Chen C; Hyeon T
ACS Nano; 2015 Dec; 9(12):12425-35. PubMed ID: 26567968
[TBL] [Abstract][Full Text] [Related]
12. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
13. Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent.
Ni D; Shen Z; Zhang J; Zhang C; Wu R; Liu J; Yi M; Wang J; Yao Z; Bu W; Shi J
ACS Nano; 2016 Mar; 10(3):3783-90. PubMed ID: 26910513
[TBL] [Abstract][Full Text] [Related]
14. Contrast agents for MRI.
Shokrollahi H
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
[TBL] [Abstract][Full Text] [Related]
15. A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.
Gholami YH; Yuan H; Wilks MQ; Maschmeyer R; Normandin MD; Josephson L; El Fakhri G; Kuncic Z
Int J Nanomedicine; 2020; 15():1253-1266. PubMed ID: 32161456
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Fe3O4/SiO2/Gd2O(CO3)2 core/shell/shell nanoparticles as T1 and T2 dual mode MRI contrast agent.
Yang M; Gao L; Liu K; Luo C; Wang Y; Yu L; Peng H; Zhang W
Talanta; 2015 Jan; 131():661-5. PubMed ID: 25281156
[TBL] [Abstract][Full Text] [Related]
18. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
19. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
Ahmed N; Ahmad NM; Fessi H; Elaissari A
Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
[TBL] [Abstract][Full Text] [Related]
20. Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.
Sharma VK; Alipour A; Soran-Erdem Z; Aykut ZG; Demir HV
Nanoscale; 2015 Jun; 7(23):10519-26. PubMed ID: 26010145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
